Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis - PubMed (original) (raw)
. 1994 Nov 25;269(47):29943-8.
Affiliations
- PMID: 7961992
Free article
Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis
H Zhu et al. J Biol Chem. 1994.
Free article
Abstract
The met proto-oncogene is a receptor tyrosine kinase for hepatocyte growth factor/scatter factor (HGF/SF). HGF/SF is a multifunctional cytokine that stimulates mitogenesis, motility, invasion, and tubulogenesis of a spectrum of epithelial and endothelial cells in culture. Using a chimeric receptor (CSF-MET), containing the extracellular domain of the colony stimulating factor-1 (CSF-1) receptor fused to the transmembrane and intracellular domain of the Met receptor, we have previously demonstrated that activation of the Met kinase domain is sufficient to mediate the motility, invasion and morphogenic signals of HGF/SF in Madin-Darby canine kidney epithelial cells (MDCK). In this study we have analyzed the role of tyrosine phosphorylation of the Met receptor in the transmission of these signals by site-directed mutagenesis of specific tyrosine residues. Mutation of two tyrosine residues (tyrosine 1234 and tyrosine 1235), involved in activation of the catalytic activity of the kinase, abrogates the biological activity of the chimera. In addition, we have identified a single noncatalytic tyrosine residue (tyrosine 1356) in the carboxyl terminus of the Met receptor, that is essential for the biological activity of the chimeric receptor. Mutation of tyrosine 1356 to a nonphosphorylatable phenylalanine residue does not affect the exogenous kinase activity of the receptor toward enolase, but it impairs the ability of the mutant protein to associate with the adaptor protein Grb2, and MDCK cells expressing this mutant fail to scatter, invade, and form branching tubules in response to CSF-1. These results support a crucial role for tyrosine 1356 in activation of signaling pathways involved in the biological activity of the Met receptor in response to HGF/SF.
Similar articles
- Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase.
Royal I, Park M. Royal I, et al. J Biol Chem. 1995 Nov 17;270(46):27780-7. doi: 10.1074/jbc.270.46.27780. J Biol Chem. 1995. PMID: 7499247 - Differential requirement of Grb2 and PI3-kinase in HGF/SF-induced cell motility and tubulogenesis.
Royal I, Fournier TM, Park M. Royal I, et al. J Cell Physiol. 1997 Nov;173(2):196-201. doi: 10.1002/(SICI)1097-4652(199711)173:2<196::AID-JCP20>3.0.CO;2-D. J Cell Physiol. 1997. PMID: 9365521 - Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
Bardelli A, Ponzetto C, Comoglio PM. Bardelli A, et al. J Biotechnol. 1994 Sep 30;37(2):109-22. doi: 10.1016/0168-1656(94)90002-7. J Biotechnol. 1994. PMID: 7765452 Review. - Molecular characteristics of HGF-SF and its role in cell motility and invasion.
Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W. Weidner KM, et al. EXS. 1993;65:311-28. EXS. 1993. PMID: 8380739 Review.
Cited by
- Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.
Fournier TM, Lamorte L, Maroun CR, Lupher M, Band H, Langdon W, Park M. Fournier TM, et al. Mol Biol Cell. 2000 Oct;11(10):3397-410. doi: 10.1091/mbc.11.10.3397. Mol Biol Cell. 2000. PMID: 11029044 Free PMC article. - Crosstalk between the alpha2beta1 integrin and c-met/HGF-R regulates innate immunity.
McCall-Culbreath KD, Li Z, Zutter MM. McCall-Culbreath KD, et al. Blood. 2008 Apr 1;111(7):3562-70. doi: 10.1182/blood-2007-08-107664. Epub 2008 Jan 15. Blood. 2008. PMID: 18198349 Free PMC article. - Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.
Yi S, Chen JR, Viallet J, Schwall RH, Nakamura T, Tsao MS. Yi S, et al. Br J Cancer. 1998 Jun;77(12):2162-70. doi: 10.1038/bjc.1998.361. Br J Cancer. 1998. PMID: 9649128 Free PMC article. - Has programmed cell death ligand-1 MET an accomplice in non-small cell lung cancer?-a narrative review.
Dempke WCM, Fenchel K. Dempke WCM, et al. Transl Lung Cancer Res. 2021 Jun;10(6):2667-2682. doi: 10.21037/tlcr-21-124. Transl Lung Cancer Res. 2021. PMID: 34295669 Free PMC article. Review. - Receptor-type Protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma.
Xu Y, Zhou J, Carey TE, McHugh JB, Voorhees JJ, Fisher GJ. Xu Y, et al. Neoplasia. 2012 Nov;14(11):1015-22. doi: 10.1593/neo.12870. Neoplasia. 2012. PMID: 23226095 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous